Article
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle
13 Mar 2024
Abstract excerpt
Glioblastoma (GBM) is characterized by significant heterogeneity, leading to poor survival outcomes for patients, despite the implementation of comprehensive treatment strategies. The roles of cyclin A2 (CCNA2) and NIMA related kinase 2 (NEK2) have been extensively studied in numerous cancers, but their specific functions in GBM remain to be elucidated. The present study aimed to investigate the potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
